Clinical Trial Update: Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML） [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating decitabine with a modified CAG regimen followed by haploidentical peripheral blood mononuclear cell infusion in elderly patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Aclarubicin (aclarubicin)
• CYTARABINE (CYTARABINE)
• Decitabine (Decitabine)
• Filgrastim (filgrastim)
• HLA haploidentical peripheral blood mononuclear cell infusion

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: MDS, AML | Phase 1, Phase 2 | Status: COMPLETED